Publication of a pathogenic mechanism triggered by mast cells in the ALS spinal cord that can be targeted by masitinib
19/08/2021 – AB Science announced the publication of a pathogenic mechanism triggered by mast cells in the amyotrophic lateral sclerosis (ALS) spinal cord that can be targeted by masitinib